PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2013. Start Trial.
Date Value
November 13, 2026 8.182
November 12, 2026 8.253
November 11, 2026 8.754
November 10, 2026 8.584
November 09, 2026 8.799
November 06, 2026 7.992
November 05, 2026 7.912
November 04, 2026 8.413
November 03, 2026 8.233
November 02, 2026 8.313
October 30, 2026 8.493
October 29, 2026 8.904
October 28, 2026 9.125
October 27, 2026 8.834
October 26, 2026 8.423
October 23, 2026 8.223
October 22, 2026 8.273
October 21, 2026 8.052
October 20, 2026 8.524
October 19, 2026 8.503
October 16, 2026 8.373
October 15, 2026 8.524
October 14, 2026 8.393
October 13, 2026 8.383
October 12, 2026 8.453
Date Value
October 09, 2026 8.864
October 08, 2026 8.634
October 07, 2026 8.503
October 06, 2026 8.042
October 05, 2026 8.293
October 02, 2026 8.383
October 01, 2026 8.564
September 30, 2026 8.403
September 29, 2026 8.611
September 28, 2026 8.552
September 25, 2026 8.130
September 24, 2026 8.160
September 23, 2026 8.513
September 22, 2026 8.817
September 21, 2026 8.346
September 18, 2026 8.415
September 17, 2026 8.297
September 16, 2026 8.081
September 15, 2026 8.169
September 14, 2026 8.689
September 11, 2026 8.758
September 10, 2026 8.846
September 09, 2026 9.121
September 08, 2026 9.356
September 04, 2026 9.631

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Alkermes Plc 4.548
Amarin Corp. Plc 1.348
Agenus, Inc. 2.327
Amgen, Inc. 6.457
Anika Therapeutics, Inc. 1.442

PS Ratio Related Metrics

Price to Book Value 1.525
Price 7.985
Earnings Yield -5.93%
Market Cap 409.96M